Pluristem Therapeutics: Up on deal with UAE stem cell firm to develop therapies

Pluri

17/08/2020 12:51

** U.S.-listed shares of biotech co  PSTI.O  up 8.1% at
$9.43 premarket 
    ** Israel's Pluristem to partner with UAE-based Abu Dhabi
Stem Cells Center to develop therapies for diseases, including
COVID-19  urn:newsml:reuters.com:*:nL8N2FJ26K
    ** Announcement comes days after Israel and UAE agreed to
normalize relations  urn:newsml:reuters.com:*:nL1N2FF1FZ
    ** Cos to exchange research results, share samples and
combine usage of equipment and testing to advance cell therapies
    ** Stock has risen 121.3% this year

 (Reporting by Sanjana Shivdas in Bengaluru)
 ((SanjanaSitara.Shivdas@thomsonreuters.com; within U.S. +1 646
223 8780, outside U.S. +91 80 6749 1642; Twitter:
@SanjanaShivdas;))